Overview

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetic properties and safety after administration of HCP1105 and co-administration of HGP0918, HGP0816 in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited